Prime Minister Narendra Modi visits Bharat Biotech Facility in Genome Valley
INFODEA Correspondent
Hyderabad
“We are humbled by the visit of Prime Minister Shri. Narendra Modi Ji to the Bharat Biotech manufacturing facility in Genome Valley, Hyderabad today,” said the company in a press statement.
Bharat Biotech is a leader in pandemic vaccines and we are truly honoured by this recognition.
“The prime minister’s visit serves as a great inspiration to our team, and further reinforces our commitment towards scientific discovery, solving public health issues, and the nation’s fight against COVID-19. COVAXIN™ India’s first indigenous vaccine with the Phase 3 clinical trial underway, is the first, largest, and the only efficacy trial in the developing world, involving many volunteers across 25 sites,” the vaccine manufacturing company said.
The COVAXIN™ phase III trial is being conducted across India in 26,000 participants. The vaccine will be produced in the only-of-its-kind Biosafety Level 3 production facility in the world.
“We take this opportunity to thank the Government of India, Regulators, our vaccine development partners, medical fraternity, medical investigators including hospitals for their relentless assistance and cooperation in the development of vaccines, also phase 3 clinical trials for COVAXIN™,” the company said.
We greatly appreciate every volunteer who has come forward for the trial thus far and we thank you for your service to the nation. Bharat reiterates our commitment towards developing a safe and efficacious vaccine for all, it added.
